Transplantation Medicine

Clinical Benefits Of Immunosuppressant Equal Economic Advantages

Published in Drug Week, November 9th, 2001

The costs associated with kidney transplantation may be cut by using a more effective immunosuppressant that reduces the level of organ rejection, a major European study has revealed.

Results of this cost-effectiveness study were announced by Dr. A. Vianello of Treviso Transplant Centre (Treviso, Italy), at the 10th Congress of the European Society for Organ Transplantation (ESOT), held in Lisbon, Portugal.

The costs of transplantation begin with the transplant procedure itself. In the longer term, the major costs are, firstly, the cost of immunosuppressant drugs to prevent rejection, and secondly, the cost of treating patients should these drugs...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2001-11-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry